| Cigarette smoking and carotid plaque echodensity in the Northern Manhattan Study D Yang, S Iyer, H Gardener, D Della-Morte, M Crisby, C Dong, K Cheung, ... Cerebrovascular Diseases 40 (3-4), 136-143, 2015 | 47 | 2015 |
| The treatment of acute promyelocytic leukemia in 2023: paradigm, advances, and future directions SG Iyer, L Elias, M Stanchina, J Watts Frontiers in Oncology 12, 1062524, 2023 | 24 | 2023 |
| Prevalence of targetable mutations in Black patients with lung cancer: a systematic review and meta-analysis PA Costa, EE Saul, Y Paul, S Iyer, LL da Silva, L Tamariz, G Lopes JCO oncology practice 17 (5), e629-e636, 2021 | 21 | 2021 |
| Role of baseline echocardiography in the preoperative management of liver transplant candidates ME Harinstein, S Iyer, MA Mathier, JD Flaherty, P Fontes, RM Planinsic, ... The American journal of cardiology 110 (12), 1852-1855, 2012 | 19 | 2012 |
| Case of anti-Zic4 antibody-mediated cerebellar toxicity induced by dual checkpoint inhibition in head and neck squamous cell carcinoma SG Iyer, NS Khakoo, G Aitcheson, C Perez BMJ Case Reports CP 13 (9), e235607, 2020 | 11 | 2020 |
| Diagnostic bone marrow biopsy in patients with stage I EMZL treated with radiation therapy: needed or not? JP Alderuccio, D Isrow, IM Reis, SG Iyer, JJ Meshman, W Zhao, F Vega, ... Blood, The Journal of the American Society of Hematology 135 (15), 1299-1302, 2020 | 10 | 2020 |
| Clinical and radiological characteristics of patients with pulmonary marginal zone lymphoma: a single center analysis M Husnain, R Kuker, IM Reis, SG Iyer, W Zhao, JR Chapman, F Vega, ... Cancer medicine 9 (14), 5051-5064, 2020 | 9 | 2020 |
| Profile of glasdegib for the treatment of newly diagnosed acute myeloid leukemia (AML): evidence to date SG Iyer, M Stanchina, TJ Bradley, J Watts Cancer management and research, 2267-2272, 2022 | 8 | 2022 |
| Prevalence and outcomes of COVID-19 among hematology/oncology patients and providers of a community-facing health system during the B1. 1.529 (“Omicron”) SARS-CoV-2 variant wave SA Kareff, A Khan, P Barreto-Coelho, SG Iyer, B Pico, M Stanchina, ... Cancers 14 (19), 4629, 2022 | 7 | 2022 |
| Long‐term outcomes of patients with conjunctival extranodal marginal zone lymphoma EE Saul, JP Alderuccio, IM Reis, W Zhao, SG Iyer, G Rodriguez, A Desai, ... American journal of hematology 98 (1), 148-158, 2023 | 6 | 2023 |
| Outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era of myeloid therapies AA Patel, JJ Yoon, H Johnston, EC Chen, M Burkart, T Seijung Oh, ... Blood 140 (Supplement 1), 6860-6862, 2022 | 6 | 2022 |
| Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era AA Patel, JJ Yoon, H Johnston, MB Davidson, RM Shallis, EC Chen, ... Blood advances 8 (13), 3468-3477, 2024 | 4 | 2024 |
| Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia E Madarang, J Lykon, W Zhao, MA Sekeres, T Bradley, NS Chandhok, ... Blood Neoplasia 1 (2), 100016, 2024 | 4 | 2024 |
| Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia G Gui, N Ravindra, PS Hegde, G Andrew, D Mukherjee, Z Wong, ... Bone marrow transplantation, 1-10, 2024 | 3 | 2024 |
| Measurable residual IDH1 before allogeneic transplant for acute myeloid leukemia G Gui, LW Dillon, N Ravindra, PS Hegde, G Andrew, D Mukherjee, ... Blood 142, 4316, 2023 | 3 | 2023 |
| Abstract B123: Prevalence of COVID-19 among hematology/oncology patients and providers of a community-facing county health system during the B1. 1.529 (“Omicron”) SARS-CoV-2 … A Khan, SA Kareff, P Barreto-Coelho, S Iyer, B Pico, M Stanchina, ... Cancer Epidemiology, Biomarkers & Prevention 32 (1_Supplement), B123-B123, 2023 | 3 | 2023 |
| Marginal zone lymphoma of the colon: case series from a single center and SEER data review A Trabolsi, JP Alderuccio, J Florindez, G Rodriguez, E Saul, SG Iyer, ... Leukemia & lymphoma 63 (5), 1160-1166, 2022 | 3 | 2022 |
| A single-center analysis of patients with extranodal marginal zone lymphoma of the breast SG Iyer, R Kuker, JA Florindez, E Saul, A Trabolsi, G Rodriguez, ... Leukemia & lymphoma 63 (3), 591-598, 2022 | 3 | 2022 |
| Use of high dose cytarabine (HiDAC) for post-remission or re-induction therapy is safe and effective in select older AML patients J Lykon, E Madarang, N Nguyen, W Li, SG Iyer, M Stanchina, T Bradley, ... Blood 138, 4422, 2021 | 3 | 2021 |
| Octogenarians with AML can have durable remissions with venetoclax and hypomethylating agent therapy despite significant dose reductions E Madarang, J Lykon, W Li, S Iyer, M Stanchina, N Nguyen, T Bradley, ... Blood 138, 1259, 2021 | 3 | 2021 |
